Publisher
Springer International Publishing
Reference73 articles.
1. Abraham, J. (1994). Bias in science and medical knowledge: The Opren controversy. Sociology, 28(3), 717–736.
https://doi.org/10.1177/0038038594028003005
.
2. Abraham, J. (1997). 6. The science and politics of medicines regulation. Sociology of Health & Illness, 19(19B), 153–182.
https://doi.org/10.1111/1467-9566.00090
.
3. Abraham, J., & Davis, C. (2013). Science, law, and the medical-industrial complex in EU pharmaceutical regulation: The Deferiprone controversy. In M. L. Flear, T. K. Hervey, & A. M. Farrell (Eds.), European law and new health technologies (1st ed., pp. 240–255). Oxford: Oxford University Press.
4. Agres, T. (2002, April 29). Euros for discoveries? The Scientist Magazine. Retrieved November 8, 2019, from
https://www.the-scientist.com/?articles.view/articleNo/14003/title/Euros-for-Discoveries-/
.
5. Angell, M. (2004). The truth about the drug companies. How they deceive us and what to do about it. New York, NY: Random House Publishing.